Growth factor- and heparin-dependent regulation of constitutive and agonist-mediated human endothelial barrier function

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 291, Issue 5, 2006, Pages

  Moy, Alan B ^a,b   Blackwell, Ken ^e   Wu, Mack H ^d   Granger, Harris J ^c  

^a Cellular Engineering Technologies Inc   (United States)

^b IA United States   (United States)

^c TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF IOWA   (United States)

Author keywords

Commercial endothelial; Epithelial growth factor; Fibroblast growth factor; Numerical modeling of transendothelial resistance; Vascular endothelial growth factor

Indexed keywords

CYCLIC AMP; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR; HEPARIN; THROMBIN; VASCULOTROPIN;

ARTICLE; CAPACITANCE BLOOD VESSEL; CELL ADHESION; CELL CULTURE; CELL FUNCTION; CELL MEMBRANE; CONTROLLED STUDY; DRUG EFFECT; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; PRIORITY JOURNAL; UMBILICAL VEIN;

CAPILLARY PERMEABILITY; CELL CULTURE TECHNIQUES; CELL LINE; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRIC IMPEDANCE; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 2; GENE EXPRESSION REGULATION; GROWTH SUBSTANCES; HEMOSTATICS; HEPARIN; HUMANS; MICROELECTRODES; THROMBIN; TIME FACTORS; UMBILICAL VEINS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 33751161462     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00185.2006     Document Type: Article

References (34)

1. Bannon PG, Kim MJ, Dean RT, and Dawes J. Augmentation of vascular endothelial barrier function by heparin and low molecular weight heparin. Thromb Haemost 73: 706-712, 1995.
2. Birukova AA, Liu F, Garcia JG, and Verin AD. Protein kinase A attenuates endothelial cell barrier dysfunction induced by microtubule disassembly. Am J Physiol Lung Cell Mol Physiol 287: L86-L93, 2004.
3. Bodmer J, English A, Brady M, Blackwell K, Haxhinasto K, Fotedar S, Borgman K, Bai E, and Moy A. Modeling error and stability of endothelial cytoskeletal-membrane parameters based on modeling transendothelial impedance as resistor and capacitor in series. Am J Physiol Cell Physiol 289: C735-C747, 2005.
4. Borsig L, Wong R, Feramisco J, Nadeau DR, Varki NM, and Varki A. Heparin and cancer revisited: mechanistic connections involving platelets, P-selectin, carcinoma mucins, and tumor metastasis. Proc Natl Acad Sci USA 98: 3352-3357, 2001.
5. Carson M, Shasby S, and Shasby DM. Histamine and inositol phosphate accumulation in endothelium: cAMP and G protein. Am J Physiol Lung Cell Mol Physiol 257: L259-L264, 1989.
6. Deprez-Roy I, Coge F, Bertry L, Galizzi JP, Feletou M, Vanhoutte PM, and Canet E. Endothelin-1 pathway in human alveolar epithelial cell line A549 and human umbilical vein endothelial cells. Acta Pharmacol Sin 21: 499-506, 2000.
7. Dvorak H, Brown L, Detmar M, and Dvorak A. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability and angiogenesis. Am J Pathol 146: 1029-1039, 1995.
8. Falanga A. Biological and clinical aspects of anticancer effects of antithrombotics. Pathophysiol Haemostasis Thrombosis 33: 389-392, 2004.
9. Gillis P, Savla U, Volpert OV, Jimenez B, Waters CM, Panos RJ, and Bouck NP. Keratinocyte growth factor induces angiogenesis and protects endothelial barrier function. J Cell Sci 112: 2049-2057, 1999.
10. Haxhinasto K, Kamath A, Blackwell K, Bodmer J, Van Heukelom J, English A, Bai E, and Moy A. Gene delivery of l-caldemon protects cytoskeletal-cell membrane integrity against adenovirus infection independent of myosin ATPase and actin assembly. Am J Physiol Cell Physiol 287: C1125-C1138, 2004.
11. Igarashi Y, Utsumi H, Chiba H, Yamada-Sasamori Y, Tobioka H, Kamimura Y, Furuuchi K, Kokai Y, Nakagawa T, Mori M, and Sawada N. Glial cell line-derived neurotrophic factor induces barrier function of endothelial cells forming the blood-brain barrier. Biochem Biophys Res Commun 261: 108-112, 1999.
12. Jacobson JR, Dudek SM, Birukov KG, Ye SQ, Grigoryev DN, Girgis RE, and Garcia JG. Cytoskeletal activation and altered gene expression in endothelial barrier regulation by simvastatin. Am J Respir Cell Mol Biol 30: 662-670, 2004.
13. Kang SS, Gosselin C, Ren D, and Greisler HP. Selective stimulation of endothelial cell proliferation with inhibition of smooth muscle cell proliferation by fibroblast growth factor-1 plus heparin delivered from fibrin glue suspensions. Surgery 118: 280-287, 1995.
14. Klein S, Giancotti FG, Presta M, Albelda SM, Buck CA, and Rifkin DB. Basic fibroblast growth factor modulates integrin expression in microvascular endothelial cells. Mol Biol Cell 4: 973-982, 1993.
15. Laird AD, Vajkoczy P, Shawver LK, Thurnher A, Liang C, Mohammadi M, Schlessinger J, Ullrich A, Hubbard SR, Blake RA, Fong TA, Strawn LM, Sun L, Tang C, Hawtin R, Tang F, Shenoy N, Hirth KP, McMahon G, and Cherrington. SU6668 is a potent antiangiogenic and antitumor agent that induces regression of established tumors. Cancer Res 60: 4152-4160, 2000.
16. Liu F, Schaphorst KL, Verin AD, Jacobs K, Birukova A, Day RM, Bogatcheva N, Bottaro DP, and Garcia JG. Hepatocyte growth factor enhances endothelial cell barrier function and cortical cytoskeletal rearrangement: potential role of glycogen synthase kinase-3β. FASEB J 16: 950-962, 2002.
17. Ludwig RJ, Boehme B, Podda M, Henschler R, Jager E, Tandi C, Boehncke WH, Zollner TM, Kaufmann R, and Gille J. Endothelial P-selectin as a target of heparin action in experimental melanoma lung metastasis. Cancer Res 64: 2743-2750, 2004.
18. Miller J, Adamis A, and Shima D. Vascular endothelial growth factor/vascular permeability factor is temporally and spatially correlated with iocular angiogenesis in primate model. Am J Pathol 145: 574-584, 1994.
19. Moy A, Blackwell K, and Kamath A. Differential effects of histamine and thrombin on endothelial barrier function through actin-myosin tension. Am J Physiol Heart Circ Physiol 282: H21-H29, 2002.
20. 20-dependent tension development. Am J Physiol Lung Cell Mol Physiol 274: L1024-L1029, 1998.
21. Moy A, Scott B, Shasby S, and Shasby DM. The effect of histamine and cyclic adenosine monophosphate on myosin light chain phosphorylation in human umbilical vein endothelial cells. J Clin Invest 92: 1198-1206, 1993.
22. Moy AB, Blackwell K, Wang N, Haxhinasto K, Kasiske MK, Bodmer J, Reyes G, and English A. Phorbol ester-mediated pulmonary artery endothelial barrier dysfunction through regulation of actin cytoskeletal mechanics. Am J Physiol Lung Cell Mol Physiol 287: L153-L167, 2004.
23. Moy AB, Van Engelenhoven J, Bodmer J, Kamath J, Keese C, Giaever I, Shasby S, and Shasby DM. Histamine and thrombin modulate endothelial focal adhesion through centripetal and centrifugal forces. J Clin Invest 97: 1020-1027, 1996.
24. Moy AB, Winter M, Kamath A, Blackwell K, Reyes G, Giaever I, Keese C, and Shasby DM. Histamine alters endothelial barrier function at cell-cell and cell-matrix sites. Am J Physiol Lung Cell Mol Physiol 278: L888-L898, 2000.
25. Ng SS, Gutschow M, Weiss M, Hauschildt S, Teubert U, Hecker TK, Luzzio FA, Kruger EA, Eger K, and Figg WD. Antiangiogenic activity of N-substituted and tetrafluorinated thalidomide analogues. Cancer Res 63: 3189-3194, 2003.
26. Parandoosh Z, Bogowitz CA, and Nova MP. A fluorometric assay for the measurement of endothelial cell density in vitro. In Vitro Cell Dev Biol Animal 34: 772-776, 1998.
27. Plopper GE, McNamee HP, Dike LE, Bojanowski K, and Ingber DE. Convergence of integrin and growth factor receptor signaling pathways within the focal adhesion complex. Mol Biol Cell 6: 1349-1365, 1995.
28. Sanderson RD. Heparan sulfate proteoglycans in invasion and metastasis. Cell Dev Biol 12: 89-98, 2001.
29. Sanderson RD, Yang Y, Suva LJ, and Kelly T. Heparan sulfate proteoglycans and heparanase partners in osteolytic tumor growth and metastasis. Matrix Biol 23: 341-352, 2004.
30. Shasby DM, Stevens T, Ries D, Moy AB, Kamath JM, Kamath AM, and Shasby SS. Thrombin inhibits myosin light chain dephosphorylation in endothelial cells. Am J Physiol Lung Cell Mol Physiol 272: L311-L319, 1997.
31. Shikata Y, Birukov KG, Birukova AA, Verin A, and Garcia JG. Involvement of site-specific FAK phosphorylation in sphingosine-1 phosphate- and thrombin-induced focal adhesion remodeling: role of Src and GIT. FASEB J 17: 2240-2249, 2003.
32. Weis S, Cui J, Barnes L, and Cheresh D. Endothelial barrier disruption by VEGF-mediated Src activity potentiates tumor cell extravasation and metastasis. J Cell Biol 167: 223-229, 2004.
33. Wu MH, Guo M, Yuan SY, and Granger HJ. Focal adhesion kinase mediates porcine venular hyperpermeability elicited by vascular endothelial growth factor. J Physiol 552: 691-699, 2003.
34. Zacharski LR, Hommann M, and Kaufmann R. Rationale for clinical trials of coagulation: reactive drugs in hepatocellular carcinoma. Expert Rev Cardiovasc Ther 2: 777-784, 2004.